In CHF, BBs improve LVEF and survival, yet their efficacy in HFpEF and acute decompensation is variable and strongly influenced by genetic polymorphisms such as ADRB1 Arg389 and GRK5 Leu41 [15,16,89,91,92,93,94]. The gene discussed is GRK5; the disease is congestive heart failure.